Qualitative Analysis of the Design and Implementation of Benefit-Sharing Programs for Biologics Across Europe

ConclusionsTo realize the full potential of benefit-sharing programs, we identify the importance of (i) setting up and timely monitoring success indicators for these programs; (ii) including quality of care and access to care parameters as success indicators; (iii) establishing clear pathways for the transparent redistribution/reinvestment of savings and (iv) transparently communicating with patients about the outcomes of benefit-sharing programs.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research